Moreover, CALR promotes epidermal growth factor (EGF)-triggered EMT via the Integrin/EGFR/ERK/MAPK pathway and alters intracellular Ca2+ levels in the pancreatic cancer cells [42]. This evidence concerns the gene EGF and pancreatic neoplasm.